Actinium Pharmaceuticals, Inc. (ATNM)
1.17
+0.08
(+7.34%)
USD |
NYAM |
Apr 07, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals EPS Diluted (Quarterly) : -0.1904 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -1.858 |
| Altimmune, Inc. | -0.2719 |
| Aldeyra Therapeutics, Inc. | -0.1074 |
| Avanos Medical, Inc. | -0.028 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.94M |
| Total Expenses (Quarterly) | 5.94M |
| Enterprise Value | -9.595M |
| Earnings Yield | -86.50% |
| Normalized Earnings Yield | -86.50 |